Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2006Current Opinion in Oncology

Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRichard WM van der MaazenJRJohn RaemaekersRadboud University Nijmegen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maazen et al. (2006) studied this question.

synapsesocial.com/papers/6aa92fd3d4068ead4b8cb2ebhttps://doi.org/10.1097/01.cco.0000245315.05263.fb
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Low-Dose Involved Field Radiation after Chemotherapy in Advanced Hodgkin Disease: A Southwest Oncology Group Randomized Study1994 · 175 citations
  2. 2Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.1998 · 227 citations
  3. 3Current treatment strategies of the German Hodgkin Study Group (GHSG)2005 · 26 citations
  4. 4Preoperative transfusion in sickle cell disease: a survey of practice in England2005 · 50 citations
  5. 5Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease2004 · 279 citations